PHASE 1/2 STUDY: FRONTLINE BRENTUXIMAB VEDOTIN plus AVD IN PEDIATRIC PTS WITH ADVANCED HODGKIN LYMPHOMA

被引：0
|
作者：
Franklin, Anna [1 ]
Zecca, Marco [1 ]
Fagioli, Franca [1 ]
Luisi, Flavio Augusto [1 ]
Song, Gregory [1 ]
Suri, Ajit [1 ]
Leonard, E. Jane [1 ]
Locatelli, Franco [1 ]
机构：
[1] Childrens Hosp Colorado, Aurora, CO USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE 1/2 STUDY DESIGN: FRONTLINE BRENTUXIMAB VEDOTIN plus AVD IN PEDIATRIC ADVANCED HODGKIN LYMPHOMA
    Franklin, Anna
    Zecca, Marco
    Luisi, Flavio Augusto
    Song, Gregory
    Suri, Ajit
    Leonard, E. Jane
    Locatelli, Franco
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [2] Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma
    Ansell, Stephen M.
    Connors, Joseph M.
    Park, Steven I.
    O'Meara, Megan M.
    Younes, Anas
    BLOOD, 2012, 120 (21)
  • [3] Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma
    Younes, Anas
    Connors, Joseph M.
    Park, Steven I.
    Hunder, Naomi N. H.
    Ansell, Stephen M.
    BLOOD, 2011, 118 (21) : 436 - 437
  • [4] Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients With Hodgkin Lymphoma Aged ≥60 Years
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 8 - 9
  • [5] Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years
    Yasenchak, Christopher A.
    Bordoni, Rodolfo
    Yazbeck, Victor
    Patel-Donnelly, Dipti
    Anderson, Thomas
    Larson, Timothy
    Newhook, Trevor
    Mei, Matthew
    Ho, Linda
    Friedberg, Jonathan W.
    BLOOD, 2019, 134
  • [6] Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A plus AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL).
    Keating Franklin, Anna Rachel
    Luisi, Flavio
    Pianovski, Mara
    Salvino, Marco Aurelio
    Fagioli, Franca
    Epelman, Sidnei
    Lima, Luciana
    Norris, Robin Elizabeth
    Odone-Filho, Vicente
    Zecca, Marco
    Favre, Claudio
    Kobayashi, Ryoji
    Koga, Yuhki
    Sidi, Yulia
    Zhou, Xiaofei
    Bai, Xiang
    Campana, Frank
    Leonard, E. Jane
    Locatelli, Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Results from an Open-Label, Phase 1/2 Study of Frontline Brentuximab Vedotin Plus Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients with Advanced Stage Hodgkin Lymphoma
    Franklin, A.
    Luisi, F.
    Pianovski, M.
    Salvino, M.
    Fagioli, F.
    Epelman, S.
    De Abreu Lima, L. B.
    Norris, R.
    Filho, V. O.
    Zecca, M.
    Favre, C.
    Kobayashi, R.
    Koga, Y.
    Sidi, Y.
    Campana, F.
    Leonard, E. J.
    Locatelli, F.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S78 - S79
  • [8] Brentuximab Vedotin Plus AVD for Non-Bulky Limited Stage Classical Hodgkin Lymphoma: A Phase 2 Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 17 - 18
  • [9] SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
    Herrera, Alex F.
    Li, Hongli
    Castellino, Sharon M.
    Rutherford, Sarah C.
    Davison, Kelly
    Evans, Andrew G.
    Punnett, Angela
    Constine, Louis S.
    Hodgson, David C.
    Parsons, Susan K.
    Prica, Anca
    Kostakoglu, Lale
    Shipp, Margaret A.
    Laubach, Cara
    Leblanc, Michael L.
    Crump, Michael
    Kahl, Brad S.
    Leonard, John P.
    Kelly, Kara M.
    Smith, Sonali M.
    Friedberg, Jonathan W.
    BLOOD, 2020, 136
  • [10] A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD
    Sorella, S.
    Assanto, G. M.
    D'Elia, Gianna Maria
    Annechini, Giorgia
    Totaro, Matteo
    Celia, Renata
    Bruno, Leonardo
    Placidi, Fabio
    Martelli, M.
    Del Giudice, I.
    LEUKEMIA & LYMPHOMA, 2024, 65 (12) : 1913 - 1916
12345